» Articles » PMID: 16735504

APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Jun 1
PMID 16735504
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

The human cytidine deaminase family APOBEC3 represents a novel group of proteins in the field of innate defense mechanisms that has been shown to be active against a variety of retroviruses. Here we examined whether members of the APO-BEC3 family have an impact on retrotransposition of human long interspersed nuclear elements (LINE-1s or L1s). Using a retrotransposition reporter assay in HeLa cells, we demonstrate that in the presence of transiently transfected APOBEC3A, L1 retrotransposition frequency was reduced by up to 85%. Although APOBEC3G and -3H did not influence L1 retrotransposition notably, expression of APOBEC3B, -3C, and -3F inhibited transposition by approximately 75%. Although reverse transcription of L1s occurs in the nucleus and APOBEC3 proteins are believed to act via DNA deamination during reverse transcription, activity against L1 retrotransposition was not correlated with nuclear localization of APOBEC3s. We demonstrate that APOBEC3C and APOBEC3B were endogenously expressed in HeLa cells. Accordingly, down-regulation of APOBEC3C by RNA interference enhanced L1 retrotransposition by approximately 78%. Sequence analyses of de novo L1 retrotransposition events that occurred in the presence of overexpressed APOBEC3 proteins as well as the analyses of pre-existing endogenous L1 elements did not reveal an enhanced rate of G-to-A transitions, pointing to a mechanism independent of DNA deamination. This study presents evidence for a role of host-encoded APOBEC3 proteins in the regulation of L1 retrotransposition.

Citing Articles

Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.

Butt Y, Sakhtemani R, Mohamad-Ramshan R, Lawrence M, Bhagwat A Nat Commun. 2024; 15(1):2369.

PMID: 38499553 PMC: 10948833. DOI: 10.1038/s41467-024-46231-w.


LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities.

Mendez-Dorantes C, Burns K Genes Dev. 2023; 37(21-24):948-967.

PMID: 38092519 PMC: 10760644. DOI: 10.1101/gad.351051.123.


Schlafen-5 inhibits LINE-1 retrotransposition.

Ding J, Wang S, Liu Q, Duan Y, Cheng T, Ye Z iScience. 2023; 26(10):107968.

PMID: 37810251 PMC: 10551903. DOI: 10.1016/j.isci.2023.107968.


Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.

Kim K, Shi A, Kelley K, Chen X J Mol Biol. 2023; 435(17):168198.

PMID: 37442413 PMC: 10528890. DOI: 10.1016/j.jmb.2023.168198.


MOV10 recruits DCP2 to decap human LINE-1 RNA by forming large cytoplasmic granules with phase separation properties.

Liu Q, Yi D, Ding J, Mao Y, Wang S, Ma L EMBO Rep. 2023; 24(9):e56512.

PMID: 37437058 PMC: 10481665. DOI: 10.15252/embr.202256512.